Ritonavir Form III: A Coincidental Concurrent Discovery

Stephan D. Parent; Pamela A. Smith; Dale K. Purcell; Daniel T. Smith; Susan J. Bogdanowich-Knipp; Ami S. Bhavsar; Larry R. Chan; Jordan M. Croom; Haley C. Bauser; Andrew McCalip; Stephen R. Byrn; Adrian Radocea

doi:10.1021/acs.cgd.2c01017

journal article Open Access Dec 21, 2022

Ritonavir Form III: A Coincidental Concurrent Discovery

Stephan D. Parent Pamela A. Smith Dale K. Purcell Daniel T. Smith Susan J. Bogdanowich-Knipp Ami S. Bhavsar Larry R. Chan Jordan M. Croom Haley C. Bauser

Andrew McCalip Stephen R. Byrn Adrian Radocea

Crystal Growth & Design Vol. 23 No. 1 pp. 320-325 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acs.cgd.2c01017

Topics

No keywords indexed for this article. Browse by subject →

References

29

[1]

Ritonavir: An Extraordinary Example of Conformational Polymorphism

John Bauer, Stephen Spanton, Rodger Henry et al.

Pharmaceutical Research 10.1023/a:1011052932607

[2]

Disappearing Polymorphs Revisited

Dejan‐Krešimir Bučar, Robert W. Lancaster, Joel Bernstein

Angewandte Chemie International Edition 10.1002/anie.201410356

[3]

10.1021/op000023y

[4]

10.1073/pnas.0437744100

[5]

10.1021/ar00052a005

[6]

10.1021/jacs.8b11528

[7]

10.1021/ja002113o

[8]

10.1016/s0025-5408(98)00086-5

[9]

10.1016/s0378-5173(98)00205-1

[10]

Bernstein J. (2020) 10.1093/oso/9780199655441.001.0001

[11]

10.1016/j.ajps.2014.05.002

[12]

10.1039/c2ce06167h

[13]

Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening

Chong-Hui Gu, Hua Li, Rajesh B Gandhi et al.

International Journal of Pharmaceutics 10.1016/j.ijpharm.2004.06.021

[14]

Solanki P. V. World J. Pharm. Sci. (2015)

[15]

10.1002/jps.21153

[16]

10.1021/ac034205c

[17]

10.1038/ncomms8793

[18]

10.1016/j.cherd.2020.12.012

[19]

10.1021/acs.cgd.7b01145

[20]

10.1021/cg3000075

[21]

10.1007/s11095-017-2265-5

[22]

10.1002/jps.10566

[23]

10.1016/j.ijpx.2019.100035

[24]

10.1021/mp400679m

[25]

10.26434/chemrxiv-2022-35fwp

[26]

10.1107/s002188902019878

[27]

10.1107/s0021889881009618

[28]

Davey R. (2006)

[29]

10.1002/app.31588

Metrics

19

Citations

29

References

Details

Published: Dec 21, 2022
Vol/Issue: 23(1)
Pages: 320-325
License: View

Authors

S

Stephan D. Parent

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

P

Pamela A. Smith

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

D

Dale K. Purcell

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

D

Daniel T. Smith

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

S

Susan J. Bogdanowich-Knipp

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

A

Ami S. Bhavsar

Varda Space Industries, El Segundo, California 90245, United States

L

Larry R. Chan

Varda Space Industries, El Segundo, California 90245, United States

J

Jordan M. Croom

Varda Space Industries, El Segundo, California 90245, United States

H

Haley C. Bauser

Varda Space Industries, El Segundo, California 90245, United States

A

Andrew McCalip

Varda Space Industries, El Segundo, California 90245, United States

S

Stephen R. Byrn

Improved Pharma LLC, West Lafayette, Indiana 47906, United States

A

Adrian Radocea

Varda Space Industries, El Segundo, California 90245, United States

Cite This Article

Stephan D. Parent, Pamela A. Smith, Dale K. Purcell, et al. (2022). Ritonavir Form III: A Coincidental Concurrent Discovery. Crystal Growth & Design, 23(1), 320-325. https://doi.org/10.1021/acs.cgd.2c01017

Ritonavir Form III: A Coincidental Concurrent Discovery

You May Also Like